Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Otsuka Pharmaceutical
Ownership Structure: publicly traded
Headquartered in: Japan
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
| State/Local | $3,472,299 | 63 |
| Federal (grants and allocated tax credits) | $2,059,106 | 7 |
| TOTAL | $5,531,405 | 70 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards: Earliest year of data: 2004. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2013.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
| New Jersey | $1,449,375 | 1 |
| Maryland | $1,136,624 | 16 |
| Alabama | $647,141 | 43 |
| California | $239,159 | 3 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
| Company | Location | Subsidy Source | Year | Subsidy Value  . | Loan/Bailout Value | Type of Subsidy |
| Otsuka America Pharmaceutical, Inc. & Otsuka | New Jersey | state | 2009 | $1,449,375 | | grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2003 | $507,402 | | federal grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2002 | $501,441 | | federal grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2004 | $399,915 | | federal grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2005 | $350,348 | | federal grant |
| PHARMAVITE LLC | California | state | 2011 | $209,316 | | training reimbursement |
| Otsuka America, Inc. | Maryland | state | 2005 | $195,386 | | tax credit/rebate |
| AVANIR PHARMACEUTICALS | United States | federal | 2000 | $100,000 | | federal grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2003 | $100,000 | | federal grant |
| AVANIR PHARMACEUTICALS | United States | federal | 2003 | $100,000 | | federal grant |
| Otsuka America Pharmaceutical, Inc. | Maryland | state | 2008 | $96,916 | | tax credit/rebate |
| Otsuka American Pharmaceutical, Inc. | Maryland | state | 2007 | $92,420 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2015 | $91,536 | | tax credit/rebate |
| Otsuka America, Inc. & Subsidiaries | Maryland | state | 2018 | $68,671 | | tax credit/rebate |
| Otsuka America, Inc. c/o Otsuka America Pharmaceutical, Inc. | Maryland | state | 2009 | $65,411 | | tax credit/rebate |
| Otsuka America Inc. | Maryland | state | 2010 | $65,321 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2016 | $63,252 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2011 | $60,998 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2012 | $59,756 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2014 | $59,756 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2017 | $58,747 | | tax credit/rebate |
| Otsuka America, Inc. & Subsidiaries | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
| Otsuka America, Inc. | Maryland | state | 2004 | $47,393 | | tax credit/rebate |
| Pharmavite LLC | Alabama | state | 2013 | $32,600 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $32,600 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $32,600 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $32,600 | | cost reimbursement |
| Otsuka America, Inc. & Subsidiaries | Maryland | state | 2020 | $26,857 | | tax credit/rebate |
| Otsuka America, Inc. & Subsidiaries | Maryland | state | 2019 | $26,526 | | tax credit/rebate |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $20,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $19,463 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $19,463 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $19,463 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $19,463 | | cost reimbursement |
| PHARMAVITE LLC | California | state | 2014 | $17,618 | | training reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $15,400 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $15,400 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $15,400 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $15,400 | | cost reimbursement |
| AVANIR PHARMACEUTICALS INC | California | state | 2017 | $12,225 | | training reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $11,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $11,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $11,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $11,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,675 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,675 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,675 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,675 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $10,000 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,550 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,550 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,550 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,550 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,524 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,524 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,524 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $8,524 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $7,800 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $7,293 | | cost reimbursement |
| Pharmavite LLC | Alabama | state | 2013 | $7,200 | | cost reimbursement |
